Biosafety decisions and perceived commercial risks: the role of GM-free private standards
This study investigates the observed discrepancy between real and perceived commercial risks associated with the use of genetically modified (GM) products in developing countries. <br> It focus particularly on the effects of GM-free private standards set up by food companies in Europe and other countries on biotechnology and biosafety policy decisions in food-exporting developing countries.